文献速递神经肿瘤

胶质母细胞瘤术后影像检查时机:大不列颠及爱尔兰实践评估(INTERVAL-GB)——多中心队列研究

Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study.
PubMed 文献 · J Neurooncol · 2024-08-06

该多中心回顾性观察性队列研究纳入2018年8月至2019年2月确诊WHO 4级胶质瘤并接受肿瘤治疗的患者,评估术后MRI随访实践与NICE和EANO推荐的一致性。结果显示,NICE和EANO随访MRI推荐依从率分别为52.8%和24.9%;按NICE或EANO推荐进行随访的时间增加与更长总生存期相关,但与无进展生存期无关。

要点

  • NICE和EANO随访MRI推荐依从率分别为52.8%(398/754)和24.9%(188/754)。
  • 按NICE推荐随访时间增加与更长OS相关(HR 0.56,95%CI 0.46-0.66,P<0.001),与PFS无关。
  • 按EANO推荐随访时间增加与更长OS相关(HR 0.54,95%CI 0.45-0.63,P<0.001),与PFS无关。

核心结论

  • 规律随访复查与胶质母细胞瘤患者更长总生存期相关,但需前瞻性试验确定规律或症状导向MRI是否影响结局。

研究设计与样本

  • 多中心、回顾性观察性队列研究,纳入2018年8月至2019年2月确诊WHO 4级胶质瘤并接受肿瘤治疗的患者754例,来自26个神经肿瘤中心,中位年龄63岁(IQR 54-70)。

主要发现

  • 接受减瘤手术的患者中,78.0%(407/522)在术后72小时内完成术后MRI,64.2%(335/522)在术后48小时内完成。
  • 后续随访MRI中位次数为1次(IQR 0-4),随访总人月数为10,100(中位12.5人月/人,IQR 5.2-19.4)。
  • NICE和EANO随访MRI推荐依从率分别为52.8%(398/754)和24.9%(188/754)。
  • 按NICE推荐随访时间增加与更长OS相关(HR 0.56,95%CI 0.46-0.66,P<0.001),与PFS无关(HR 0.93,95%CI 0.79-1.10,P=0.349)。
  • 按EANO推荐随访时间增加与更长OS相关(HR 0.54,95%CI 0.45-0.63,P<0.001),与PFS无关(HR 0.99,95%CI 0.84-1.16,P=0.874)。

关键数值与推荐

  • NICE推荐:术后扫描<72小时,每3-6个月MRI。
  • EANO推荐:术后扫描<48小时,每3个月MRI。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Post-operative MRI is used to assess extent of resection, monitor treatment response and detect progression in high-grade glioma. However, compliance with accepted guidelines for follow-up MRI, and impact on management/outcomes is unclear. METHODS: Multi-center, retrospective observational cohort study of patients with confirmed WHO grade 4 glioma (August 2018-February 2019) receiving oncological treatment. PRIMARY OBJECTIVE: investigate follow-up MRI surveillance practice and compliance with recommendations from NICE (Post-operative scan < 72h, MRI every 3-6 months) and EANO (Post-operative scan < 48h, MRI every 3 months). RESULTS: There were 754 patients from 26 neuro-oncology centers with a median age of 63 years (IQR 54-70), yielding 10,100 (median, 12.5/person, IQR 5.2-19.4) person-months of follow-up. Of patients receiving debulking surgery, most patients had post-operative MRI within 72 h of surgery (78.0%, N = 407/522), and within 48 h of surgery (64.2%, N = 335/522). The median number of subsequent follow-up MRI scans was 1 (IQR 0-4). Compliance with NICE and EANO recommendations for follow-up MRI was 52.8% (N = 398/754) and 24.9% (N = 188/754), respectively. On multivariable Cox regression analysis, increased time spent in recommended follow-up according to NICE guidelines was associated with longer OS (HR 0.56, 95% CI 0.46-0.66, P < 0.001), but not PFS (HR 0.93, 95% CI 0.79-1.10, P = 0.349). Increased time spent in recommended follow-up according to EANO guidelines was associated with longer OS (HR 0.54, 95% CI 0.45-0.63, P < 0.001) but not PFS (HR 0.99, 95% CI 0.84-1.16, P = 0.874). CONCLUSION: Regular surveillance follow-up for glioblastoma is associated with longer OS. Prospective trials are needed to determine whether regular or symptom-directed MRI influences outcomes.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study. J Neurooncol. 2024. PMID: 39105956. doi:10.1007/s11060-024-04705-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。